about
Determinants of relapse periodicity in Plasmodium vivax malariaThe evolution of tafenoquine--antimalarial for a new millennium?Therapeutic responses to different antimalarial drugs in vivax malariaTafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to dateEfficacy and safety of dihydroartemisinin-piperaquine for treatment of Plasmodium vivax malaria in endemic countries: meta-analysis of randomized controlled studiesResistance to therapies for infection by Plasmodium vivaxEfficacy of three different regimens of primaquine for the prevention of relapses of Plasmodium vivax malaria in the Amazon Basin of Peru.Usefulness of seminested multiplex PCR in surveillance of imported malaria in SpainPartial protection against Plasmodium vivax blood-stage infection in Saimiri monkeys by immunization with a recombinant C-terminal fragment of merozoite surface protein 1 in block copolymer adjuvant.Clinical proteomics of the neglected human malarial parasite Plasmodium vivax.Malaria in selected non-Amazonian countries of Latin America.Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiencyRandomized trial of primaquine hypnozoitocidal efficacy when administered with artemisinin-combined blood schizontocides for radical cure of Plasmodium vivax in Indonesia.Molecular Monitoring of Plasmodium vivax Infection after Radical Treatment in Southeastern IranRandomized, open-label trial of primaquine against vivax malaria relapse in IndonesiaPlasmodium vivax blood-stage dynamicsPI4 Kinase Is a Prophylactic but Not Radical Curative Target in Plasmodium vivax-Type Malaria Parasites.alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malariaMeager genetic variability of the human malaria agent Plasmodium vivaxA prospective comparative field study to evaluate the efficacy of a traditional plant-based malaria prophylaxis.KAI407, a potent non-8-aminoquinoline compound that kills Plasmodium cynomolgi early dormant liver stage parasites in vitro.Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study.In vivo and in vitro antiplasmodial activities of some plants traditionally used in Guatemala against malaria.Inhibition of In Vivo Growth of Plasmodium berghei by Launaea taraxacifolia and Amaranthus viridis in Mice.Comparison of the OptiMAL test with PCR for diagnosis of malaria in immigrants.Evaluation of the OptiMAL test for rapid diagnosis of Plasmodium vivax and Plasmodium falciparum malariaEfficacy of Chloroquine and Primaquine for the Treatment of Uncomplicated Plasmodium vivax Malaria in Cruzeiro do Sul, Brazil.The Effect of Otostegia persica in Combination with Chloroquine on Chloroquine-Sensitive and Chloroquine-Resistant Strains of Plasmodium berghei Using In-vivo Fixed Ratios Method.An engineered vaccine of the Plasmodium vivax Duffy binding protein enhances induction of broadly neutralizing antibodies.PvaxDB: a comprehensive structural repository of Plasmodium vivax proteome.Primaquine 30 mg/day versus 15 mg/day during 14 days for the prevention of Plasmodium vivax relapses in adults in French Guiana: a historical comparison.
P2860
Q17485692-A6F8729D-E4C0-45A3-8D78-D6351010BBE5Q24536171-79D48EAF-9712-4AD1-8781-FCAF2852EE27Q24550626-E2868AE6-16FE-445B-B9EA-2B360240EBB6Q26741307-F0E785F3-1C45-427C-BC79-3AE73BCE9022Q28535686-576D35BD-A3DC-4BB5-A73F-1AA40140F54AQ33481576-15FA8AFC-F8ED-4E96-82DA-95283F6CD0FBQ33841091-B6EE523D-B404-4176-998F-EEE844F25DFCQ33962981-CA9D2264-114A-484A-B6DB-E127F03DF3A2Q34000050-D6BD2C92-4AF6-4393-806D-BFDF5D1E02B3Q34058745-F609F3E9-05B5-4893-8263-67648DABC7FCQ35613578-53C2898E-E20C-4B2B-BC2F-A9B6B2E8ED76Q35754020-12797983-425F-4F89-9B8C-92FECF1670A9Q35865488-F64A59AB-6936-480F-9C6C-5BB26A96A2E3Q36064945-B26E88CC-AF8D-4E69-B79D-3A269B1306F5Q36666980-EDAB91D4-EF4F-4FCC-AD1C-5557C735AB72Q36824070-704A9880-F884-4D27-8E27-104235C6DB08Q36887985-D6E2B67E-AA37-4606-A100-94E1E4929B8CQ37229005-9A6DB0FF-BC30-4178-A839-A3CB5719B6CCQ37569157-F9C358B9-FEE8-4037-BEB9-962750BA9DBDQ37621153-645385F8-FE81-4C03-B0CA-41C86BDA7EE3Q37643622-A0F0B19D-661B-411F-A4C2-3F82A7AE3211Q38603812-1AFAF6A0-4D47-49F4-87BA-CC28C3D76371Q39010850-EDBB589E-C680-4AD9-99E3-5F6173845D8FQ39262545-09F7FD01-7A16-4621-A628-9F98B7460F65Q39453188-AA2DC89C-B00F-4610-8696-689C4A9630C0Q39643169-90765AC1-FE32-4529-87DB-7D14116C8311Q40081673-23928D06-85A8-4E51-86D4-120496152C9BQ41929930-0FF669B8-FD49-4935-97A9-FA57B2124B8BQ47150417-E22987E4-1920-4F4C-98CF-B12E57CA2168Q52567294-37ABAD18-AF4E-419B-A179-EF75EB82F94CQ55413566-CB3D7337-92B0-4370-B421-5A08D5B6B685
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Primaquine resistance in Plasmodium vivax.
@en
type
label
Primaquine resistance in Plasmodium vivax.
@en
prefLabel
Primaquine resistance in Plasmodium vivax.
@en
P1476
Primaquine resistance in Plasmodium vivax.
@en
P2093
Jeffery GM
P304
P407
P577
1996-09-01T00:00:00Z